| Financial Year |
March 31 2023 |
| Monetary Funds |
1,330,226,571.77 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
112,453,476.28 |
| Advances to Suppliers |
5,841,734.73 |
| Other Receivables |
753,093.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
144,338,359.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
52,541,248.34 |
| Total Current Assets |
1,794,051,308.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
384,614,711.74 |
| Under-construction Projects |
140,898,896.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
170,839,854.51 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,543,077.76 |
| Deferred Income Tax Assets |
19,530,139.56 |
| Other Non-Current Assets |
60,591,627.42 |
| Sub-Total of Non-Current Assets |
788,769,678.02 |
| Total Assets |
2,582,820,986.69 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
37,676,241.00 |
| Accounts Payable |
168,201,174.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,595,166.14 |
| Taxes Payable |
18,193,848.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,422,577.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,438,361.59 |
| Other Current Liabilities |
1,478,268.55 |
| Sub-Total of Current Liabilities |
261,766,054.48 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,791,190.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
83,920,424.28 |
| Total Liabilities |
345,686,478.76 |
| Paid-In Capital(Or Share Stock) |
240,253,000.00 |
| Capital Surplus |
553,562,138.16 |
| Surplus Reserve |
120,126,500.00 |
| LESS:Treasury Stock |
7,785,720.00 |
| Undistributed Profits |
1,330,856,982.99 |
| Minority Stockholder's Interest |
121,606.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,237,012,901.15 |
| Owner's Equity（Stockholder's Equity） |
2,237,134,507.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,582,820,986.69 |
